Angioedema On November 27, 2009,<unk>  was approved by the FDA for the treatment of acute attacks of hereditary angioedema for persons over 16 years of age. A single dose requires three separate injections, which are given under the skin.<unk>  does not appear to be efficacious for the treatment of angioedema due to ACE inhibitors.
Ecallantide
Ciclopirox
Crofelemer
Chlordecone
Argyrol
Cafaminol
Tisagenlecleucel
Clinatec